Loss of Growth Factor Dependence and Conversion of Transforming Growth Factor-β1 Inhibition to Stimulation in Metastatic H-ras-transformed Murine Fibroblasts

LC Schwarz, MC Gingras, G Goldberg, AH Greenberg… - Cancer research, 1988 - AACR
LC Schwarz, MC Gingras, G Goldberg, AH Greenberg, JA Wright
Cancer research, 1988AACR
Cell lines with varying tumorigenic and metastatic potentials have been obtained by
transformation of 10T½ fibroblasts using radiation or transfection with T-24 H-ras. We have
observed an inverse relationship between metastatic potential and dependence on serum
for growth. The effects of basic fibroblast growth factor, platelet-derived growth factor,
epidermal growth factor, and transforming growth factor-β1 (TGF-β1) on these lines were
then examined to determine if the changes in the serum dependence of metastatic cells may …
Abstract
Cell lines with varying tumorigenic and metastatic potentials have been obtained by transformation of 10T½ fibroblasts using radiation or transfection with T-24 H-ras. We have observed an inverse relationship between metastatic potential and dependence on serum for growth. The effects of basic fibroblast growth factor, platelet-derived growth factor, epidermal growth factor, and transforming growth factor-β1 (TGF-β1) on these lines were then examined to determine if the changes in the serum dependence of metastatic cells may be due to altered responsiveness to specific growth factors (GFs). Cells were grown in monolayer culture and DNA synthesis was measured by [CH3-3H]thymidine incorporation experiments. Both metastatic and nonmetastatic cells were shown to be equivalent in their diminished responsiveness to basic fibroblast growth factor, platelet-derived growth factor, and epidermal growth factor as compared to their nontransformed, parental 10T½ cells. However, a unique response of metastatic cells to TGF-β1 was identified. While TGF-β1 inhibited DNA synthesis in 10T½ cells and a nonmetastatic tumor, cells with intermediate to high metastatic ability were stimulated up to 5.8-fold by TGF-β1. Interestingly, epidermal growth factor abrogated the TGF-β1 inhibition of the parental 10T½ cells, but had no effect on the TGF-β1 response of any metastatic line. Therefore, metastatic but not nonmetastatic cells, demonstrated a dramatically altered sensitivity to TGF-β1, a response which may be important in determining metastatic potential.
AACR